Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07455825) titled 'A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years' on March 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: AstraZeneca
Condition:
Healthy Participants
Intervention:
Drug: AZD5004
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: March 5, 2026
Target Sample Size: 64
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT0...